S&P 500   3,431.83 (-0.97%)
DOW   28,009.41 (-1.15%)
QQQ   282.30 (-0.86%)
AAPL   114.11 (-0.81%)
MSFT   214.11 (-0.98%)
FB   283.75 (-0.37%)
GOOGL   1,618.10 (-0.91%)
AMZN   3,193.73 (-0.33%)
TSLA   413.31 (-1.74%)
NVDA   537.54 (-1.12%)
BABA   309.88 (-0.01%)
CGC   19.60 (-0.66%)
GE   7.49 (-1.83%)
MU   52.20 (-1.23%)
AMD   82.42 (+0.56%)
T   27.56 (-0.93%)
F   8.05 (-1.35%)
ACB   4.64 (-0.85%)
GILD   60.28 (-0.84%)
NFLX   487.00 (-0.26%)
NIO   26.58 (-2.14%)
BA   164.78 (-1.54%)
DIS   126.40 (-1.52%)
S&P 500   3,431.83 (-0.97%)
DOW   28,009.41 (-1.15%)
QQQ   282.30 (-0.86%)
AAPL   114.11 (-0.81%)
MSFT   214.11 (-0.98%)
FB   283.75 (-0.37%)
GOOGL   1,618.10 (-0.91%)
AMZN   3,193.73 (-0.33%)
TSLA   413.31 (-1.74%)
NVDA   537.54 (-1.12%)
BABA   309.88 (-0.01%)
CGC   19.60 (-0.66%)
GE   7.49 (-1.83%)
MU   52.20 (-1.23%)
AMD   82.42 (+0.56%)
T   27.56 (-0.93%)
F   8.05 (-1.35%)
ACB   4.64 (-0.85%)
GILD   60.28 (-0.84%)
NFLX   487.00 (-0.26%)
NIO   26.58 (-2.14%)
BA   164.78 (-1.54%)
DIS   126.40 (-1.52%)
S&P 500   3,431.83 (-0.97%)
DOW   28,009.41 (-1.15%)
QQQ   282.30 (-0.86%)
AAPL   114.11 (-0.81%)
MSFT   214.11 (-0.98%)
FB   283.75 (-0.37%)
GOOGL   1,618.10 (-0.91%)
AMZN   3,193.73 (-0.33%)
TSLA   413.31 (-1.74%)
NVDA   537.54 (-1.12%)
BABA   309.88 (-0.01%)
CGC   19.60 (-0.66%)
GE   7.49 (-1.83%)
MU   52.20 (-1.23%)
AMD   82.42 (+0.56%)
T   27.56 (-0.93%)
F   8.05 (-1.35%)
ACB   4.64 (-0.85%)
GILD   60.28 (-0.84%)
NFLX   487.00 (-0.26%)
NIO   26.58 (-2.14%)
BA   164.78 (-1.54%)
DIS   126.40 (-1.52%)
S&P 500   3,431.83 (-0.97%)
DOW   28,009.41 (-1.15%)
QQQ   282.30 (-0.86%)
AAPL   114.11 (-0.81%)
MSFT   214.11 (-0.98%)
FB   283.75 (-0.37%)
GOOGL   1,618.10 (-0.91%)
AMZN   3,193.73 (-0.33%)
TSLA   413.31 (-1.74%)
NVDA   537.54 (-1.12%)
BABA   309.88 (-0.01%)
CGC   19.60 (-0.66%)
GE   7.49 (-1.83%)
MU   52.20 (-1.23%)
AMD   82.42 (+0.56%)
T   27.56 (-0.93%)
F   8.05 (-1.35%)
ACB   4.64 (-0.85%)
GILD   60.28 (-0.84%)
NFLX   487.00 (-0.26%)
NIO   26.58 (-2.14%)
BA   164.78 (-1.54%)
DIS   126.40 (-1.52%)
Log in
CVE:RLV

Relevium Technologies Stock Forecast, Price & News

C$0.04
-0.01 (-11.11 %)
(As of 10/23/2020 05:41 PM ET)
Add
Compare
Today's Range
C$0.04
Now: C$0.04▼
C$0.05
50-Day Range
C$0.03
MA: C$0.04▼
C$0.08
52-Week Range
C$0.01
Now: C$0.04▼
C$0.09
Volume114,000 shs
Average Volume1.22 million shs
Market CapitalizationC$7.95 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Relevium Technologies Inc. engages in the identification, evaluation, and acquisition of assets or businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and nutri cosmeceuticals primarily through its Bioganix brand portfolio online, as well as dietary supplements under the LeefyLyfe brand name through its wholesale, retail, and online distribution channels. It is also involved in the extraction, formulation, development, and encapsulation of proprietary nutraceutical products for medical purposes. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. The company was incorporated in 2012 and is headquartered in Montreal, Canada. Relevium Technologies Inc. is a subsidiary of iTech Medical, Inc.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.48 out of 5 stars

Industry, Sector and Symbol

Stock Exchange CVE
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolCVE:RLV
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.releviumcorp.com
Phone+1-514-8248559
EmployeesN/A

Debt

Debt-to-Equity Ratio74.67
Current Ratio0.37
Quick Ratio0.19

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesC$3.70 million
Price / Sales2.15
Cash FlowC$0.00 per share
Price / Cash Flow30.00
Book ValueC$0.03 per share
Price / Book1.48

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares198,846,000
Market CapC$7.95 million
Next Earnings DateN/A
OptionableNot Optionable
C$0.04
-0.01 (-11.11 %)
(As of 10/23/2020 05:41 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RLV News and Ratings via Email

Sign-up to receive the latest news and ratings for RLV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Relevium Technologies (CVE:RLV) Frequently Asked Questions

How has Relevium Technologies' stock been impacted by Coronavirus (COVID-19)?

Relevium Technologies' stock was trading at C$0.02 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, RLV shares have increased by 166.7% and is now trading at C$0.04.
View which stocks have been most impacted by COVID-19.

Who are some of Relevium Technologies' key competitors?

Some companies that are related to Relevium Technologies include Isoray (ISR), IsoRay (ISR), Akers Biosciences (AKR), Vigil Health Solutions (VGL), Ambu A/S (AMBBY), American Medical Technologies (ADLI), Ansell (ANSLY), Ansell (ANSLF), Ansell (ANN), Borqs Technologies (BTAVF), Clover Co. Limited (CLV.AX) (CLV), Coloplast A/S (CLPBF), Commerzbank (CZMWY), Convatec Group (CNVVY) and Demant A/S (WILLF).
View all competitors.

What other stocks do shareholders of Relevium Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Relevium Technologies investors own include Arctic Star Exploration (ADD), Eldorado Gold (ELD), Freedom Leaf (FRLF), Macquarie Infrastructure (MIC), Spero Therapeutics (SPRO), (TGIF) (TGIF), Acquired Sales (AQSP), Aphria Inc. (APHA.TO) (APHA), Aphria (APHA) and Aldeyra Therapeutics (ALDX).

Who are Relevium Technologies' key executives?

Relevium Technologies' management team includes the following people:
  • Mr. Aurelio Useche C.M.A., M.B.A., Pres, CEO & Director (Age 51)
  • Mr. Edward Ierfino, Mang. of Investor Relations (Age 51)
  • Mr. Wayne D. Cockburn, Consultant (Age 62)
  • Mr. Faycal Salek, Chief Financial Officer
  • Mr. Abis Hussain, Sr. Marketing Officer

What is Relevium Technologies' stock symbol?

Relevium Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "RLV."

How do I buy shares of Relevium Technologies?

Shares of RLV and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Relevium Technologies' stock price today?

One share of RLV stock can currently be purchased for approximately C$0.04.

How big of a company is Relevium Technologies?

Relevium Technologies has a market capitalization of C$7.95 million and generates C$3.70 million in revenue each year.

What is Relevium Technologies' official website?

The official website for Relevium Technologies is www.releviumcorp.com.

How can I contact Relevium Technologies?

Relevium Technologies' mailing address is 1000 Sherbrooke St W Suite 2700, MONTREAL, QC H3A 3G4, Canada. The company can be reached via phone at +1-514-8248559.

This page was last updated on 10/26/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.